DE69716901T2 - 2,4-diaminopyrimidin-derivate - Google Patents

2,4-diaminopyrimidin-derivate

Info

Publication number
DE69716901T2
DE69716901T2 DE69716901T DE69716901T DE69716901T2 DE 69716901 T2 DE69716901 T2 DE 69716901T2 DE 69716901 T DE69716901 T DE 69716901T DE 69716901 T DE69716901 T DE 69716901T DE 69716901 T2 DE69716901 T2 DE 69716901T2
Authority
DE
Germany
Prior art keywords
pyrimidine derivatives
diamino pyrimidine
diamino
derivatives
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69716901T
Other languages
English (en)
Other versions
DE69716901D1 (de
Inventor
Philippe Guerry
Henri Stalder
Pierre-Charles Wyss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Basilea Pharmaceutica AG
Original Assignee
Basilea Pharmaceutica AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica AG filed Critical Basilea Pharmaceutica AG
Application granted granted Critical
Publication of DE69716901D1 publication Critical patent/DE69716901D1/de
Publication of DE69716901T2 publication Critical patent/DE69716901T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69716901T 1996-05-15 1997-05-07 2,4-diaminopyrimidin-derivate Expired - Lifetime DE69716901T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96107739 1996-05-15
PCT/EP1997/002355 WO1997043277A1 (en) 1996-05-15 1997-05-07 2,4-diaminopyrimidine derivatives

Publications (2)

Publication Number Publication Date
DE69716901D1 DE69716901D1 (de) 2002-12-12
DE69716901T2 true DE69716901T2 (de) 2003-09-18

Family

ID=8222784

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69716901T Expired - Lifetime DE69716901T2 (de) 1996-05-15 1997-05-07 2,4-diaminopyrimidin-derivate

Country Status (29)

Country Link
US (1) US5866583A (de)
EP (1) EP0901488B1 (de)
JP (1) JP3098259B2 (de)
KR (1) KR100295509B1 (de)
CN (1) CN1098260C (de)
AR (1) AR007088A1 (de)
AT (1) ATE227282T1 (de)
AU (1) AU726416B2 (de)
BR (1) BR9709251A (de)
CA (1) CA2254117C (de)
CO (1) CO4840509A1 (de)
CY (1) CY2425B1 (de)
CZ (1) CZ364698A3 (de)
DE (1) DE69716901T2 (de)
DK (1) DK0901488T3 (de)
ES (1) ES2184089T3 (de)
HR (1) HRP970260A2 (de)
IL (1) IL126702A0 (de)
MA (1) MA24182A1 (de)
NO (1) NO985335L (de)
NZ (1) NZ332481A (de)
PE (1) PE78898A1 (de)
PL (1) PL330277A1 (de)
PT (1) PT901488E (de)
TR (1) TR199802331T2 (de)
TW (1) TW438796B (de)
WO (1) WO1997043277A1 (de)
YU (1) YU51498A (de)
ZA (1) ZA973984B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0966464B1 (de) * 1997-03-03 2003-05-28 Basilea Pharmaceutica AG Substituierte 2,4-diaminopyrimidine
CA2281642C (en) * 1997-03-03 2008-02-05 F. Hoffmann-La Roche Ag Substituted 2,4-diaminopyrimidines
US6277860B1 (en) * 1999-10-29 2001-08-21 Pfizer Inc Furopyridine antibacterials
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
WO2005011677A1 (en) * 2003-06-13 2005-02-10 Arena Pharmaceuticals, Inc. 5-substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the nicotinic acid receptor rup25 for the treatment of dyslipidemia and related diseases
CN1832741A (zh) * 2003-08-07 2006-09-13 默克公司 作为11-β-羟甾类脱氢酶-1抑制剂的吡唑甲酰胺类
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
DE102005062987A1 (de) * 2005-12-28 2007-07-05 Grünenthal GmbH Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln
JP5341084B2 (ja) * 2007-08-03 2013-11-13 エフ.ホフマン−ラ ロシュ アーゲー Taar1リガンドとしてのピリジンカルボキシアミド及びベンズアミド誘導体
RU2528406C2 (ru) * 2008-11-21 2014-09-20 Раквалиа Фарма Инк. Новое производное пиразол-3-карбоксамида, обладающее антагонистической активностью в отношении рецептора 5-нт2в
CA2750047A1 (en) * 2009-01-21 2010-07-29 Basilea Pharmaceutica Ag Novel bicyclic antibiotics
JP5753856B2 (ja) * 2009-12-15 2015-07-22 バイエル・クロップサイエンス・アーゲーBayer Cropscience Ag 1−アルキル−/1−アリール−5−ピラゾールカルボン酸誘導体を調製する方法
BR112013025792A2 (pt) 2011-04-05 2018-04-24 Pfizer Ltd Inibidores de quinase relacionada à pirrolo[2,3-d] pirimidina tropomisina
DE102013208484B4 (de) 2013-05-08 2018-04-26 Wirtgen Gmbh Vorrichtung zum Bearbeiten von Straßen- oder Bodenoberflächen, sowie Verfahren zum Lenken einer Straßenfräsmaschine
AR117169A1 (es) * 2018-11-28 2021-07-14 Bayer Ag (tio)amidas de piridazina como compuestos fungicidas

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes
US4515948A (en) * 1973-09-12 1985-05-07 Hoffmann-La Roche Inc. 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines
US4013644A (en) * 1976-03-15 1977-03-22 G. D. Searle & Co. [8 α(E), 13aβ]-5,8,13,13a-tetrahydro-2,3,10,11-tetramethoxy-8-(2-phenylethenyl)-6H-dibenzo[a,g]quinolizines and intermediates thereto
US4444770A (en) * 1980-05-29 1984-04-24 Bayer Aktiengesellschaft New imidazoazole-alkenoic acid amide compounds, intermediate products for their production, their production, and their medicinal use
US4594199A (en) * 1983-09-19 1986-06-10 E. R. Squibb & Sons, Inc. Method for making phosphinic acid intermediates
EP0639075A1 (de) * 1990-11-14 1995-02-22 Chiron Corporation Spezifische hemmung der dihydrofolsäurereduktase und wirkstoffe dafür
MX9703687A (es) * 1994-11-24 1997-08-30 Hoffmann La Roche Nuevas bencil pirimidinas.
EP0832069B1 (de) * 1995-06-07 2003-03-05 Pfizer Inc. Biphenyl-2-carbonsäure-tetrahydro-isochinolin-6-yl amid derivate, deren hestellung und deren verwendung als inhibitoren des mikrosomalen triglycerid-transfer-proteins und/oder der apolipoprotein b (apo b) sekretion
ES2169272T3 (es) * 1995-12-04 2002-07-01 Arpida Ag Diaminopirimidinas, composiciones farmaceuticas que las contienen y su utilizacion como agente antibacteriano.

Also Published As

Publication number Publication date
JPH11511749A (ja) 1999-10-12
ATE227282T1 (de) 2002-11-15
CA2254117A1 (en) 1997-11-20
AR007088A1 (es) 1999-10-13
PT901488E (pt) 2003-03-31
ES2184089T3 (es) 2003-04-01
WO1997043277A1 (en) 1997-11-20
AU726416B2 (en) 2000-11-09
EP0901488A1 (de) 1999-03-17
MA24182A1 (fr) 1997-12-31
CO4840509A1 (es) 1999-09-27
BR9709251A (pt) 1999-08-10
IL126702A0 (en) 1999-08-17
DK0901488T3 (da) 2003-03-03
CN1098260C (zh) 2003-01-08
HRP970260A2 (en) 1998-04-30
PL330277A1 (en) 1999-05-10
CZ364698A3 (cs) 1999-02-17
ZA973984B (en) 1997-11-17
NO985335D0 (no) 1998-11-16
EP0901488B1 (de) 2002-11-06
AU2894297A (en) 1997-12-05
KR20000011053A (ko) 2000-02-25
DE69716901D1 (de) 2002-12-12
US5866583A (en) 1999-02-02
CN1218465A (zh) 1999-06-02
NO985335L (no) 1999-01-15
NZ332481A (en) 2000-04-28
YU51498A (en) 1999-11-22
JP3098259B2 (ja) 2000-10-16
KR100295509B1 (ko) 2001-09-17
TW438796B (en) 2001-06-07
PE78898A1 (es) 1998-11-13
TR199802331T2 (xx) 1999-04-21
CA2254117C (en) 2003-03-11
CY2425B1 (en) 2004-11-12

Similar Documents

Publication Publication Date Title
DE69736711D1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
NL300150I2 (nl) 4 "-Gesubstitueerde 9-deoxo-9A-AZA-9A-homoërythromycine-A-derivaten.
ATE214704T1 (de) 5h-thiazolo(3,2-a)pyrimidinderivate
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
DE69718771T2 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
DE69716901D1 (de) 2,4-diaminopyrimidin-derivate
BR9507666A (pt) Novos derivados de pirimidina
MA26503A1 (fr) Derives de 5'-desoxy-cytidine.
DE69714358T2 (de) 9,10-disubstituierte campothecinderivate mit antitumoraktivität
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
DE69722064D1 (de) 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate
DE69815072D1 (de) Substituierte 2,4-diaminopyrimidine
BR9708948A (pt) 1,3 - Benzodioxois substituídos

Legal Events

Date Code Title Description
8364 No opposition during term of opposition